3 unknown, 2 completed. 5 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Unknown 3, Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Vaccination: new trials by email Literature Review of Vaccination trials Research Report on Vaccination
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts Vaccination - Palmar or Plantar Warts | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 146 | 2022-06-29 | 2025-01-23 |
| Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response Vaccination with Gardasil, Injection of Normal Saline - Genital Warts | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 300 | 2017-11-15 | 2018-02-27 |
| A Study of MG1111 in Healthy Children Varicella Vaccine - Healthy Children | Phase 2 / Phase 3 | Completed | Green Cross Corporation | 814 | 2016-11-26 | 2021-05-14 |
| Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents Vaccination with Fluval AB Novo suspension for injection, half dose of a single intramuscular dose (0.25 ml), Vaccination with Fluval AB Novo suspension for injection, single intramuscular dose (0.5 ml) - Human Influenza | Phase 3 | Completed | Fluart Innovative Vaccine Ltd, Hungary | 120 | 2014-10-01 | 2021-03-11 |
| Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients Vaccination with VZV vaccine - Liver Disease, Immunosuppression | Phase 2 / Phase 3 | Unknown | University Hospital, Geneva | 80 | 2007-06-01 | 2020-09-18 |
Chickenpox (1) · Condylomata Acuminata (1) · Influenza, Human (1) · Liver Diseases (1) · Recurrence (1) · Warts (1)
Assistance Publique - Hôpitaux de Paris (2) · Fluart Innovative Vaccine Ltd, Hungary (1) · Green Cross Corporation (1) · University Hospital, Geneva (1)
France (2) · South Korea (1) · Switzerland (1)